Literature DB >> 10606870

High-dose therapy for Hodgkin's disease.

D C Linch1, A H Goldstone.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10606870     DOI： 10.1046/j.1365-2141.1999.01570.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  1 in total

1.  Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience.

Authors:  Paolo Anderlini; Rima Saliba; Sandra Acholonu; Sergio A Giralt; Borje Andersson; Naoto T Ueno; Chitra Hosing; Issa F Khouri; Daniel Couriel; Marcos de Lima; Muzaffar H Qazilbash; Barbara Pro; Jorge Romaguera; Luis Fayad; Frederick Hagemeister; Anas Younes; Mark F Munsell; Richard E Champlin
Journal:  Haematologica       Date:  2008-01-26       Impact factor: 9.941
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.